🧫
experiment

Netrin-1 expression analysis in human endometrial carcinomas

🧫 Experiment Protocol Exploratoryendometrial carcinomaNTN1human endometrial carcinoma tissue samplesproposed
Investigation of netrin-1 upregulation in human endometrial carcinoma samples. The study examined netrin-1 expression levels across a majority of human endometrial carcinoma specimens to establish the prevalence of netrin-1 overexpression in this cancer type. This foundational analysis provided the rationale for targeting netrin-1 as a therapeutic approach in endometrial cancer, demonstrating that netrin-1 serves as a pro-tumoral mechanism in these cancers.
PRIMARY OUTCOME
netrin-1 expression levels
EXPECTED OUTCOMES
Upregulation of netrin-1 in majority of endometrial carcinomas
SUCCESS CRITERIA
Demonstration of netrin-1 overexpression in endometrial cancer samples
PROTOCOL
Expression analysis of netrin-1 in human endometrial carcinoma specimens
LINKED HYPOTHESES
Source: PMID 37532934 ↗
🧫 Experiment Extras
PATHWAY
Netrin-1 signaling pathway
MARKET PRICE
$0.50
STATUS
proposed
Related Target
NTN1composite 0.529
View on SciDEX ↗